A

Asymchem Laboratories Tianjin Co Ltd
SZSE:002821

Watchlist Manager
Asymchem Laboratories Tianjin Co Ltd
SZSE:002821
Watchlist
Price: 77.02 CNY 0.55% Market Closed
Updated: May 28, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

19.8B
+0%
Assets
Growth Rates:
1 Year
+8%
3 Years
+176%
5 Years
+521%
7 Years
+709%
10 Years
-
2.3B
-2%
Liabilities
Growth Rates:
1 Year
-12%
3 Years
+97%
5 Years
+239%
7 Years
+231%
10 Years
-
17.5B
+0.3%
Equity
Growth Rates:
1 Year
+12%
3 Years
+192%
5 Years
+596%
7 Years
+896%
10 Years
-

Balance Sheet Decomposition
Asymchem Laboratories Tianjin Co Ltd

19.8B
Assets
2.3B
Liabilities
19.8B
Assets
2.3B
Liabilities
Current Assets 12.4B
Cash & Short-Term Investments 9B
Receivables 2.3B
Other Current Assets 1B
Non-Current Assets 7.4B
Long-Term Investments 867.2m
PP&E 5.6B
Intangibles 611.8m
Other Non-Current Assets 335.6m
Current Liabilities 1.8B
Accounts Payable 453.6m
Accrued Liabilities 306.8m
Short-Term Debt 73.6m
Other Current Liabilities 966.8m
Non-Current Liabilities 486.6m
Long-Term Debt 106.5m
Other Non-Current Liabilities 380.2m

Balance Sheet
Asymchem Laboratories Tianjin Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
144
265
1 084
828
605
414
2 122
6 232
4 418
4 772
Cash
0
0
0
0
0
0
0
6 232
4 418
0
Cash Equivalents
144
265
1 084
828
605
414
2 122
0
0
4 772
Short-Term Investments
0
29
0
0
37
0
0
401
3 005
4 235
Total Receivables
246
222
327
497
569
722
1 110
2 052
2 781
2 299
Accounts Receivables
237
212
295
451
525
659
986
1 817
2 515
2 080
Other Receivables
8
10
32
46
43
64
124
236
266
219
Inventory
117
129
219
260
424
449
726
1 396
1 510
945
Other Current Assets
7
21
16
30
60
54
72
229
146
101
Total Current Assets
514
666
1 645
1 615
1 694
1 639
4 030
10 310
11 860
12 352
PP&E Net
480
532
724
921
1 311
1 674
2 360
3 697
5 056
5 601
PP&E Gross
480
532
724
921
1 311
1 674
2 360
3 697
5 056
5 601
Accumulated Depreciation
186
237
295
356
451
532
673
882
1 164
1 538
Intangible Assets
54
65
64
67
118
122
286
374
473
466
Goodwill
0
0
0
0
0
0
43
146
146
146
Long-Term Investments
0
0
0
0
0
222
305
396
390
867
Other Long-Term Assets
10
8
12
35
63
103
135
233
313
336
Other Assets
0
0
0
0
0
0
43
146
146
146
Total Assets
1 058
N/A
1 272
+20%
2 445
+92%
2 637
+8%
3 185
+21%
3 759
+18%
7 158
+90%
15 156
+112%
18 239
+20%
19 767
+8%
Liabilities
Accounts Payable
65
109
139
153
276
267
522
552
569
454
Accrued Liabilities
20
36
54
29
63
75
111
214
369
307
Short-Term Debt
50
80
187
2
5
1
12
415
58
74
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
13
28
29
Other Current Liabilities
31
12
123
190
195
161
279
1 011
1 153
938
Total Current Liabilities
166
237
504
374
540
504
925
2 205
2 177
1 801
Long-Term Debt
20
0
0
0
0
0
0
46
110
106
Deferred Income Tax
0
2
3
5
25
61
87
117
89
117
Minority Interest
40
56
79
97
0
0
0
0
48
30
Other Liabilities
88
96
105
103
111
148
151
179
168
233
Total Liabilities
313
N/A
390
+25%
691
+77%
580
-16%
675
+16%
713
+6%
1 163
+63%
2 546
+119%
2 592
+2%
2 287
-12%
Equity
Common Stock
90
90
113
230
231
231
243
263
370
369
Retained Earnings
300
433
655
939
1 287
1 748
2 355
3 274
6 364
7 969
Additional Paid In Capital
357
357
981
1 039
1 105
1 146
3 539
9 564
10 144
9 612
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
152
117
88
137
482
1 247
494
Other Equity
1
1
5
1
6
8
4
9
17
22
Total Equity
746
N/A
881
+18%
1 754
+99%
2 058
+17%
2 511
+22%
3 046
+21%
5 995
+97%
12 610
+110%
15 647
+24%
17 480
+12%
Total Liabilities & Equity
1 058
N/A
1 272
+20%
2 445
+92%
2 637
+8%
3 185
+21%
3 759
+18%
7 158
+90%
15 156
+112%
18 239
+20%
19 767
+8%
Shares Outstanding
Common Shares Outstanding
180
180
226
230
231
231
243
366
363
363

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.